Industry News
Targeting stem cells in triple-negative breast cancer
Feb 19, 2014
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease. Read More
Globally, cancer kills 50% more men than women
Feb 18, 2014
Figures published by Cancer Research UK reveal that more than 4.6 million men and 3.5 million women die of cancer worldwide every year, putting the global rate of cancer death among men (126 per 100,000) 50% higher than that of women (82 per 100,000). Read More
Post-surgery heart attack: '85% undetected due to lack of symptoms'
Feb 18, 2014
According to a study published in the journal Anesthesiology, over 8 million adults worldwide have injuries or heart attacks after surgery each year, with 10% dying within 30 days. Now, researchers say 85% of these heart attacks or injuries may be missed due to lack of symptoms. However, they suggest this could be resolved with a simple blood test following surgery. Read More
Post-surgery heart attack: '85% undetected due to lack of symptoms'
Feb 18, 2014
According to a study published in the journal Anesthesiology, over 8 million adults worldwide have injuries or heart attacks after surgery each year, with 10% dying within 30 days. Now, researchers say 85% of these heart attacks or injuries may be missed due to lack of symptoms. However, they suggest this could be resolved with a simple blood test following surgery. Read More
Nanofiber 'monorails' ferry brain tumors to their death
Feb 18, 2014
Glioblastoma is the deadliest form of brain cancer, and one reason it is difficult to treat is because tumor cells spread to other parts of the brain by following nerve fibers and blood vessels. Now, using nanofiber "monorails," biomedical engineers have found a way to hijack this migratory feature and lure the malignant cells elsewhere. Read More
Biomarker- and receptor-targeted therapies in NSCLC influence clinical trial success
Feb 18, 2014
Over the past decade, a great clinical focus has been directed at developing new and innovative therapies for advanced non-small cell lung cancer (NSCLC). An analysis of clinical trials evaluating these therapies demonstrates that the cumulative success rate for new agents for advanced NSCLC is lower than the industry-estimated rate. Read More
High frequency of EGFR mutations found in Asian population
Feb 18, 2014
Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors. Read More
To ensure correct number of chromosomes, epigenetic regulation essential
Feb 18, 2014
Abnormal number of chromosomes is often associated with cancer development. In a new study published in the journal Nature Structural and Molecular Biology researchers at Karolinska Institutet in Sweden have shown that a subtle epigenetic change plays an important role in the correct segregation of chromosomes. Read More
'Moving' pediatric brain tumors by hijacking cancer migration mechanism
Feb 18, 2014
One factor that makes glioblastoma cancers so difficult to treat is that malignant cells from the tumors spread throughout the brain by following nerve fibers and blood vessels to invade new locations. Now, researchers have learned to hijack this migratory mechanism, turning it against the cancer by using a film of nanofibers thinner than human hair to lure tumor cells away. Read More
Improvements in colon cancer survival largely reflect gains among non-elderly whites and Asians
Feb 18, 2014
While new and better treatments have improved the odds of survival for patients diagnosed with late stage colorectal cancer, that progress has been largely confined to non-Hispanic whites and Asians and those under age 65, according to a new study. American Cancer Society researchers led by Helmneh Sineshaw, M.D. Read More
Previous Page Next Page